methylprednisolone has been researched along with Hantavirus Pulmonary Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belmar, E; Calvo, M; Castillo, C; Cuiza, A; Díaz, R; Ferres, M; Hernandez, C; Lee, SJ; Martinez, J; Mertz, GJ; Rioseco, ML; Riquelme, R; Scholz, L; Valdivieso, F; Vial, PA | 1 |
1 trial(s) available for methylprednisolone and Hantavirus Pulmonary Syndrome
Article | Year |
---|---|
High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial.
Topics: Administration, Intravenous; Adolescent; Adult; Anti-Inflammatory Agents; Chile; Double-Blind Method; Female; Hantavirus Pulmonary Syndrome; Humans; Kaplan-Meier Estimate; Male; Methylprednisolone; Middle Aged; Orthohantavirus; RNA, Viral; Treatment Outcome | 2013 |